Mediolanum International Funds Ltd Lowers Stock Position in Agilent Technologies, Inc. $A

Mediolanum International Funds Ltd reduced its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 30.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 15,900 shares of the medical research company’s stock after selling 7,074 shares during the period. Mediolanum International Funds Ltd’s holdings in Agilent Technologies were worth $1,781,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in Agilent Technologies by 4.3% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock valued at $82,712,000 after buying an additional 24,687 shares during the period. Massachusetts Financial Services Co. MA grew its position in shares of Agilent Technologies by 13.8% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock worth $1,925,064,000 after buying an additional 1,713,216 shares during the last quarter. CCLA Investment Management increased its position in Agilent Technologies by 1.9% during the 4th quarter. CCLA Investment Management now owns 1,047,488 shares of the medical research company’s stock valued at $142,542,000 after purchasing an additional 19,518 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Agilent Technologies by 20.9% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after buying an additional 9,236 shares during the period. Finally, Crossmark Global Holdings Inc. raised its position in shares of Agilent Technologies by 39.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock worth $4,615,000 after acquiring an additional 9,615 shares in the last quarter. Institutional investors own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

A has been the subject of a number of recent research reports. Piper Sandler began coverage on shares of Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 price target for the company. Jefferies Financial Group began coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Two analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $159.35.

Agilent Technologies Stock Up 2.1%

NYSE A opened at $133.04 on Wednesday. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $160.27. The company has a market capitalization of $37.58 billion, a P/E ratio of 26.72, a P/E/G ratio of 2.31 and a beta of 1.25. The stock has a 50 day moving average price of $128.27 and a 200-day moving average price of $125.47. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The firm had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm posted $1.31 EPS. The business’s quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, equities analysts predict that Agilent Technologies, Inc. will post 6.01 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a yield of 0.8%. Agilent Technologies’s payout ratio is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.